Evolving Treatment Paradigms in Ph+ ALL

Switching From MA to TM Increases Mental Health Care Use: Angela Liu, PhD, MPH

December 23rd 2025

Top 5 Trending FDA Approvals of 2025

Angela Liu, PhD, MPH, speaks about her study that examined mental health care use by Medicare beneficiaries before and after switching from MA to TM.

Listen

Top 5 Trending FDA Drug Approvals of 2025 | Image Credit: Venngage

December 31st 2025

Managed Care Cast Presents: New Evidence and Economic Considerations in IPF Care

These pieces highlight several newly approved therapies that expanded treatment options across multiple disease states.

November 25th 2025

Top 5 Most-Read Dermatology Content of 2025

Experts discuss the clinical and economic burden of idiopathic pulmonary fibrosis (IPF), emerging clinical data, and strategies to improve patient outcomes.

Listen

Explore the top dermatology innovations of 2025, from AI-enabled devices to new biologics and emerging treatments for complex skin conditions.

ICYMI: Highlights From ASH 2025

Our top dermatology content of 2025 highlights AI wearables, new biologics, emerging vitiligo treatments, and strategies for rare and complex skin diseases.

‘Our Responsibility Should Be to Give You the Closest Thing to a Normal Life’

ASH 2025 highlighted innovative cancer treatments, including in vivo CAR T therapy and options that enhance quality of life while reducing burdens.

Related Content

January 2nd 2026

Switching From MA to TM Increases Mental Health Care Use: Angela Liu, PhD, MPH

December 23rd 2025

Top 5 Trending FDA Approvals of 2025

Angela Liu, PhD, MPH, speaks about her study that examined mental health care use by Medicare beneficiaries before and after switching from MA to TM.

Listen

December 31st 2025

Managed Care Cast Presents: New Evidence and Economic Considerations in IPF Care

These pieces highlight several newly approved therapies that expanded treatment options across multiple disease states.

November 25th 2025

Top 5 Most-Read Dermatology Content of 2025

Experts discuss the clinical and economic burden of idiopathic pulmonary fibrosis (IPF), emerging clinical data, and strategies to improve patient outcomes.

Listen

ICYMI: Highlights From ASH 2025

Our top dermatology content of 2025 highlights AI wearables, new biologics, emerging vitiligo treatments, and strategies for rare and complex skin diseases.